Background. The use of and demand for echocardiography (ECHO) has increased worldwide. In developed countries, this has not translated into improved access outside tertiary centres. Previous studies have favoured the appropriate use of ECHO over its clinical impact, limiting generalisability to resourceconstrained settings. Objectives. To assess the impact of an ECHO service at district hospital level in Cape Town, South Africa. Methods. A prospective, crosssectional study was performed. A total of 210 consecutive patients, referred to the ECHO clinic over a 5month period, were recruited. Transthoracic ECHO was evaluated in terms of its indication, new information provided, correlation with the referring doctor's diagnosis and subsequent management plan. Impact included the escalation and deescalation of treatment, as well as usefulness without a change in management. Results. The results show that 83.8% of the patients' management was impacted on by echocardiography. Valvular lesions were the main indication. The most frequent contribution was information provided towards the diagnosis of heart failure and assessment after myocardial infarction. Of the echocardiograms, 56.2% confirmed the referring doctor's diagnosis, yet were still associated with a significant impact. The rational prescription of medication had the major impetus, followed by deescalation of therapy and screening patients to determine referral to a tertiary facility. Conclusion. ECHO has a positive impact on patient management outside tertiary settings, where the definition of impact appears to be different. The value of a normal study, screening prior to upstream referral and usefulness irrespective of change have been established. This should alert policy makers against restriction of access to ECHO and promote training of personnel in its use.
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The use of and demand for echocardiography (ECHO) have shown a marked increase worldwide. [1] As a 'special' investigation it has the potential to pro vide accurate haemodynamic as well as anatomical information noninvasively at the bedside. [13] Developing countries are showing a steady rise in noncommuni cable diseases (NCDs), with cardiovascular diseases proving the largest burden in South Africa (SA). [4, 5] The dual burden of communicable diseases and NCDs is disproportionately affecting vulnerable lower income groups in urban settings. [4] Ironically, patients accessing hospitals with the least available specialist expertise have been shown to have the highest number of comorbidities. [6] Access to investigations such as ECHO, traditionally and often exclusively at the hands of specialist cardiologists, remains restricted and uneven in SA.
Recent advances in the developed world include openaccess echocardiography (OAE), which is requested and the results acted on by general practitioners, handheld devices, and pointofcare studies by noncardiologists. [2, 79] Apart from their usefulness in screening patients, appropriate care can be implemented at an earlier stage and waiting times for, or referrals to, tertiary care can be reduced. The main limitation for the rollout of ECHO to primary healthcare settings is the lack of training of personnel. [10] A few recent studies have reviewed the utility of ECHO in large, mainly tertiary centres in the developed world.
[1113] The use is driven mainly by appropriateuse criteria (AUC). These AUC identify common clinical scenarios in which ECHO can be applied and aim at improving health outcomes by means of the equitable allocation of resources in cardiovascular imaging. [14] There is a paucity of data regarding the impact of ECHO in subSaharan Africa. Various definitions of impact and the different concepts of a district or general hospital limit the generalisability to resourceconstrained areas, where, paradoxically, the clinical impact of ECHO may be of more value than the traditionally accepted clinical indications.
Objectives
To assess the clinical impact of an ECHO service in a district hospital in SA. Further conclusions on the demand to access and need for training in echocardiography were possible.
Methods
A prospective, descriptive, crosssectional study was conducted at Victoria Hospital, a districtlevel hospital in Cape Town, SA, serving a patient population (in 2014) of nearly 600 000, mainly of low and middle socioeconomic status. The study cohort consisted of patients referred to the onceweekly ECHO service during the 14week period between September 2013 and January 2014.
Recruitment of study participants was achieved on the day of the prebooked ECHO appointments. All in and outpatient referrals were considered, regardless of age and comorbidities. Patients unable to give written consent were excluded. Only screening transthoracic echocardiography (TTE) was included. It was performed by a registered cardiologist, accredited to perform ECHO.
October 2015, Vol. 105, No. 10 EpiCalc (freeware, version 1.02, 2000) was used to calculate the sample size. It was assumed that 80% of management decisions would change following results of the ECHO. To achieve a confidence level of 95% with a precision of 5% (i.e. a margin of error of 10%), a sample size of 245 patients was required.
Data were collected prospectively, as the ECHO was performed. A questionnaire concerning patient characteristics and medical history was completed by the participant with the help of a research assistant. The cardiologist who performed the ECHO completed a second questionnaire in order to establish the impact of the ECHO by assessing the indication for the investigation, new information obtained, correlation with the referring doctor's diagnosis and the management plan thereafter. AUC were used to classify indications explicitly. The average waiting period was randomly calculated on four dates, reviewing the time until the next available appointment.
The cardiologist used a Toshiba Nemio machine with an adult ECHO probe PST 25AT (1.8 4.2 mHz). The patients were screened in the supine and left lateral positions. Examinations were viewed in real time and done in standard trans thoracic views, parasternal long and short axis with apical fourchamber views; subxyphoid views were included when indicated. Mmode, 2D and colour flow Doppler were utilised. The ejection fraction was measured using the Teicholz method. Regional wall motion was visually evaluated in the abovementioned views. Continuous Doppler was not available on the machine, but colour flow Doppler was used when necessary. Mmode recording was done and printed out when deemed necessary, but not stored. The ECHOs performed were for screening purposes only and were not standard transthoracic evaluations. Even though some patients had repeated TTE, most patients did not have a baseline standard study.
Impact was classified according to adapted criteria (Table 1) .
[1113] 
Statistical analysis

Ethical considerations
This study was approved by the Health Science Research Ethics Committee of the University of Cape Town (HREC 382/2013). Each participant gave written consent to participate in the study, and a study number was allocated to each in order to ensure confidentiality.
Results
A total of 210 participants were recrui ted ( Fig. 1 ). Approximately onethird of the patients did not attend on their appointment date. The majority of the participants were referred by the Department of Medicine, either from the ward or via the Outpatient Department (Table 2) .
Selfreported and documented comorbi dities included 9 HIVpositive participants (4.3%), 5 with rheumatic heart disease (2.8%) and 4 with a previous mitral valve replacement (2.3%), all associated with impact. It was not documented whether these valve replacements were initially indicated for rheumatic heart disease. Of the participants, 131 (62.4%) had a history of smoking, onethird of these indicating a current smoking habit. Of those older than 
Clinical utility and association with impact
We found that 83.8% of TTEs had an impact on the patient' s management. In total, 51.0% of ECHOs resulted in an escalation of management, and 19.0% in deescalation, while 13.8% had an impact without a change of management.
Valvular lesions were the main indication for referral (Table 3) . Only one patient's indication was seen as inappropriate when compared with the AUC. [14] The major contribution of TTE was the information provided to aid the diagnosis of heart failure (29.0%) and ischaemic heart disease (23.8%) ( Table 4) . Of all participants, onethird had impaired left ventricular (LV) function. Three cases of apical thrombus were identified after myocardial infarction, which resulted in the initiation of anticoagulation therapy.
The most common valvular lesions identified, in order of prevalence, are listed in Table 4 . Of these, mitral stenosis, discerning aortic scleroses from stenosis, identifying nonpathological murmurs and aortic regurgitations were statistically significantly associated with clinical impact. In addition to the five participants known to have rheumatic heart disease prior to the TTE, three further cases were diagnosed, the total prevalence being 3.8% in our study cohort.
Six participants were diagnosed with cor pulmonale and four with pulmonary hypertension; none of these was known to be suffering from chronic obstructive pulmonary disease.
Despite the fact that 56.2% of all TTEs (n=118) confirmed the referring doctor's diagnosis, these ECHOs were still significantly linked to impact (confidence interval 0.64 0.80). In 39.1% (n=82) the prereferral diag nosis was contested and in 4.8% (n=10) it was unknown. Of the 34 TTEs that did not have an impact, 88.2% (n=30) correlated with the prereferral diagnosis.
Spectrum of clinical impact
TTE was found to be most useful in the rational prescription of medication (n=80). Twentyseven participants, onefifth of those who had an escalation in manage ment, required referral to tertiary services (Fig. 2 ). Of these upstream referrals, 9 patients were referred for surgery: 5 were for valve replacements, 3 for the correction of atrial septal defects and 1 for surgery of an atrial myxoma. Three patients, with severe disease, required referral to the hospital's social worker for a disability grant.
Deescalation of care, with return to pri mary healthcare services, was recommended in 40 cases. Fifteen participants were offered reassurance for nonpathological murmurs and six participants for idiopathic chest pain, preventing further testing or referral to a higher level of care. The remainder benefited in that TTE ruled out cardiac sources of emboli, structural causes for Behavioural advice, for example direct advice on alcohol consumption, weight reduc tion and smoking cessation, was docu mented but not analysed. Three female patients with postpartum cardiomyopathy were advised against future pregnancies.
Discussion
We found that the majority (83.8%) of ECHOs had a positive impact on patients referred to a district hospital -a proportion much higher than that previously reported in developed country settings of 32 76%. [12, 13] The diversity of patients' ages, comorbidities and sources of referral revealed the broad value of this investigative modality. The value of a prospective study is that single ECHO assessment in a nontertiary setting can immediately address a focused, clinical question or suspicion raised, and may have an immediate impact. Our definition of impact is different from previous larger impact studies, undertaken either in tertiary settings or in community hospitals with specialised cardiology services. [12, 13] A few older studies done at district hospitals either reviewed the impact more than 30 years ago, using only Mmode ECHO, or focused on intensive care units. [3, 15, 16] The lack of generalisability to current district hospital practice seems obvious, especially in resourceconstrained settings.
Fig. 2. Upstream referrals (impact or upstream referral clinic, number of cases, percentage of escalated management) after ECHO. (CMO = cardiomyopathy; ECG = electrocardiogram.)
We have established the role of ECHO in causing deescalation in therapy and continuation of management at district hospital level. This potential for decreasing referral to tertiary specialists seems similar to other studies. [7, 9, 16] Previous studies have cautioned against undervaluing a study with normal findings. [8, 11, 17] This latter benefit was confirmed in 32.9% (n=69) of all the participants referred, without escalating management. Its use in screening prescreened patients is evident, with a particularly high impact level in all paediatric patients, mainly aiding in deescalation of services relating to a murmur that had been auscultated prior to referral. This has been undervalued by previous studies. [12, 15] Our study has shown that impact does not necessarily translate into a change in managementmany patients without a change in clinical status require followup, which is seen as a valid indication in itself in early and late stages of cardiac disease. [14] The major change in management proved to be rational prescription of medication. The other main benefit was determining which patients required upreferral to tertiary services, e.g. for cardiac surgery.
AUC are not used in SA. Nevertheless, only one participant's indication could not be classified according to AUC, as the referral was for possible cardiac cause for seizures. This indicates the high level of appropriate use of ECHOs in our district hospital. The most common indication was suspected valve disease. Its significance could not be statistically linked to impact, perhaps owing to the small sample size achieved. New information gathered was nevertheless significant for mitral stenosis and aortic regurgitation, mirroring the finding of a previous audit of the beneficial value of ECHO in assessing diastolic (more than systolic) murmurs. [15] Three adult participants but no paediatric patients were newly diagnosed with rheumatic heart disease. A recent study in SA has shown the decrease in rheumatic heart disease in children in SA, which may be due to improved access to healthcare and an improved socioeconomic environment. [18] The use of ECHO as a screening tool for rheumatic heart disease has yet to be translated into impact on prognosis and effective secondary prophylaxis for subclinical disease. Results suggest that adults may benefit from screening more than children. [19] Of all indications for ECHO, assessment of regional wall motion abnormalities and suspected hypertensive heart disease were statistically significantly associated with impact. The value of ECHO in defining prognosis in these two conditions has been described previously. [20, 21] One study found that the evaluation of wall motion abnormalities constitutes the most statistically significant, independent prognostic data provided by TTE. [20] Although screening of all hypertensive patients has been recommended, as left ventricular hypertrophy itself implies a worse prognosis, [22] others assert that ECHO confirmation would probably not intensify the treatment of the hypertension itself. [22, 23] In our study, heart failure was the major indication for ECHO, as was the case in a systematic review of patients referred for OAE from primary care. [23] The role of TTE in providing new information in this context is nonetheless unsurpassed, by detecting LV dysfunction and either establishing or confirming the cause of failure. [17] This is of particular value in our setting, where heart failure is usually diagnosed and monitored by clinical means only. Despite twothirds of the cohort having a smoking history, low numbers of cases of COPD and its complications were reported. Screening for and assessing cardiac complications, such as cor pulmonale and pulmonary hypertension, in patients with COPD can be useful, as both infer increased morbidity and mortality. [24] The diagnosis of a clinically unsuspected atrial myxoma in this small cohort was a finding that would otherwise have remained undetected.
Discrepancies between the results of the TTEs and the assessment of the referring clinician prior to the test were confirmed, as per previous studies. [25, 26] It appears that the positive impact of TTE is independent of the clinical accuracy of the referring doctor. On the other hand, a lack of impact was nonetheless associated with accurate prereferral assessment. This may indicate that a thorough history and physical examination may lessen the need for a diagnostic test. [25] Thirtynine percent of the ECHOs disproved the prereferral diagnosis.
In some of the participants who had had previous TTEs, repeat ECHO nevertheless had an important clinical impact. An earlier study found that the added diagnostic value of a repeat ECHO is significantly independent of whether the test had been performed previously. [25] Approximately onefifth of patients were referred from the hospital's emergency department; this may indicate the need for training in questionfocused, pointofcare studies. A review of TTEs performed by noncardiologists showed an active change in management in 16 37% of patients in an emergency setting. [9] Failure of referral of patients from primary healthcare facilities was found despite doctors being free to refer patients directly for TTEs; it is not clear whether the medical staff were unaware of the existence of the service. Notably, among the few patients in this study cohort who were referred from community healthcare settings, the ECHOs had an important impact.
The waiting time for the next available appointment was six times as long as the recommended time period of 2 weeks advised by the National Institute for Care Excellence guidelines for patients with chronic heart failure and after myocardial infarction. [27] A Dutch study of OAE reports a waiting time of 5 weeks. [7] In developing countries, a lack of resources and scarce skills may be the reason for this long waiting time. The poor socioeconomic status of our participants, including pensioners and those receiving disability grants, suggests a reliance on public sector facilities. The poor attendance for TTE appointments shows the undervaluing of this restricted resource. Nonattendance is often due to lack of funds for transport. Having this service only at a distant tertiary centre may add to poor attendance.
Study limitations
Our study does have limitations. The participants were referred from the hospital ward or outpatient departments and had been prescreened after being admitted via the emergency department or referred from a primary healthcare facility. This may overvalue the impact owing to a lower incidence of negative findings. Patients with acute cardiac illness, such as heart failure or myocardial infarction, may be more likely to benefit from ECHO. The inclusion of hospitalised patients probably increased the likelihood of appropriate referrals by doctors. [11] The ECHOs were performed by an experienced cardiologist, with this specialist assessment in itself likely to have an impact on patient management, causing impact to be overestimated. The risk of possible bias exists, as the October 2015, Vol. 105, No. 10 cardiologist was involved in the clinical decisionmaking process and management of participants. The study size was smaller than initially anticipated, mainly because of patients defaulting on their appointments.
Following the participants' completion of the questionnaires, all data were checked to correlate with the clinical information in their folders. This allowed for more accurate analysis of the patient characteristics and the echocardiograms as well as their indications. Fifteen patient folders were missing and were not checked retrospectively.
The downstream risks of TTE, such as incorrect interpretation and residual anxiety despite a normal study, should not be disre garded. [1, 14, 28] It would be important to gain insight into whether clinical impact and changes in management eventually translate into improved health outcomes in primary healthcare. These effects could be assessed in a followup study. Other than its clinical impact, the cost implications of a restricted resource should be studied. The benefits of more accurate diagnosis, improving rational drug prescription and decreasing the burden on the tertiary healthcare system should be evaluated. A patientcentred approach can also evaluate patients' own perception of impact on their illness.
Conclusion
Echocardiography had a positive impact on patient management in a district hospital setting. Limited access for patients may negatively impact on their management, as a valuable contribution of TTEs to overall management was found. A normal ECHO is important in offering reassurance to patients and diagnostic assistance to the referring doctor, and aiding in referral back to the primary level of care. In the overburdened public health sector, where continuity of care is frequently a problem, it may reduce time and costs. By providing an ECHO service in nontertiary settings, patients can be screened and more appropriately referred to scarce upstream specialists and subspecialist departments.
Training in interpretation and accreditation in the use of ECHO should be a priority for teaching and academic facilities, especially for personnel working in general, emergency and family medicine. The prospect of handheld devices would definitely enhance access, but may compromise quality.
Policy makers should be alerted to the added value offered by an ECHO assessment. The rapidly growing burden of NCDs should encourage investment in such servicebased interventions to local communities. [4] District hospitals can establish protocols in the communities they serve, to assist with procurement and referrals from primary health care.
